Conference Coverage
-
Conference Coverage
MS and COVID: Docs switched DMTs but maybe didn’t need to
Switching was rampant early on, a survey finds, but a new study suggests specific drugs don’t boost risk.
-
Conference Coverage
Vegetable fats tied to lower stroke risk, animal fats to higher risk
Higher intake of vegetable fats, such as olive oil and nuts, was associated with a lower risk for stroke, and animal fats, especially processed...
-
Conference Coverage
New blood test may detect preclinical Alzheimer’s years in advance
“We believe this has the potential to radically improve early stratification and identification of patients for trials 6 years in advance of a...
-
Conference Coverage
Visual snow: Alarming and not uncommon
As many as 3% of the population may experience this visual abnormality, but it’s usually benign.
-
Conference Coverage
Optimal epilepsy care extends well beyond managing seizures
Among patients with epilepsy, common comorbidities include anxiety and mood disorders, hypertension, back problems, developmental disorders,...
-
Conference Coverage
‘Alarming’ rate of abuse in pregnant women with epilepsy
Women with epilepsy are also more likely to report other stressors, including divorce, illness, lost pay, and partner discord, while expecting.
-
Conference Coverage
More brain aging observed in older patients with child-onset epilepsy
It’s not clear how the deterioration may affect day-to-day cognition.
Latest News
-
From the Journals
Coffee or tea? Drinking both tied to lower stroke, dementia risk
Drinking coffee or tea reduces the risk for stroke and dementia. But drinking both reduces stroke risk by 30% and dementia risk by 28%.
-
From the Journals
Yoga effective adjunct therapy in recurrent vasovagal syncope
Adding a regular yoga regimen to standard therapy can reduce symptoms and improve quality of life in patients with frequent fainting spells, or...
Literature Review
-
Literature Review
Largest ever review of new daily persistent headache assesses its clinical features
“Future prospective studies are needed to better understand this disabling disorder.”
-
Literature Review
Erenumab beats topiramate for migraine in first head-to-head trial
The findings suggest that erenumab may help overcome longstanding issues with migraine medication adherence.
-
Literature Review
AAN issues ethical guidance on controversial Alzheimer’s drug
The statement aims to help clinicians communicate the uncertainty over aducanumab’s risks and potential benefits.
-
Literature Review
Hypertension may double the risk of late-onset epilepsy
“Our findings further expand upon our knowledge of the negative effects hypertension has on brain health.”
-
Literature Review
Could Viagra help prevent Alzheimer’s?
“Being able to repurpose a drug already licensed for health conditions could help speed up the drug discovery process and bring about life-...
-
From the Journals
Are newer migraine therapies better? It depends
“Triptans will be around for a long time, but the newer medications are here to stay,”